Mitochondrial dysfunction activates a translational stress response that drives diabetic pain

Neuropathic pain is common and debilitating among diabetics. The reactive glycolytic metabolite methylglyoxal (MGO) is strongly associated with painful diabetic neuropathy. MGO triggers pain through activation of the integrated stress response (ISR). The underlying molecular mechanisms are unclear. Here, we show that general control nonderepressible 2 (GCN2) kinase acts as a conserved sensor that bridges glycolytic and mitochondrial dysfunction to pain hypersensitivity. In human sensory neurons derived from dorsal root ganglion (DRG), MGO increased eIF2α phosphorylation and suppressed global translation. These effects were blocked upon inhibition of GCN2. Unbiased ribosome profiling of mouse DRG revealed that MGO triggered repression of mRNAs that encode components of the electron transport chain. Based on this observation, mitochondrial dysfunction was examined as a potential upstream trigger for GCN2 activation. MGO directly glycated mitochondrial complex I and increased the NADH/NAD+ ratio. Correcting this redox imbalance via expression of a mitochondrial-targeted bacterial NADH oxidase (mitoLbNOX) prevented ISR activation by MGO. In a streptozotocin-induced mouse model of diabetic neuropathy, pharmacological GCN2 inhibition or sensory neuron-specific conditional deletion significantly attenuated mechanical allodynia. Calcium imaging revealed that genetic deletion of GCN2 reduced calcium influx in response to an agonist of TRPA1. Finally, expression of mitoLbNOX using adeno-associated viruses (AAV) in DRG sensory neurons in vivo reduced streptozotocin-induced mechanical hypersensitivity. Our findings demonstrate that GCN2 is a central, conserved driver of translational dysregulation downstream of mitochondrial redox stress in diabetic pain. This work highlights the critical role of mitochondrial function and translational control as key drivers of painful diabetic neuropathy.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-13
DOI
https://doi.org/10.64898/2026.11.11.765941
Primary Topic
Pain Mechanisms and Treatments
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Mitochondrial dysfunction activates a translational stress response that drives diabetic pain

Zachary T. Campbell, Alexander R. Mikesell, Rebecca Chase, Guadalupe García et al.
4 links
bioRxiv (Cold Spring Harbor Laboratory)
Pain Mechanisms and Treatments
preprint

Mitochondrial dysfunction activates a translational stress response that drives diabetic pain

Zachary T. Campbell, Alexander R. Mikesell, Rebecca Chase, Guadalupe García, Angela R. Meyer, Jacob B. Shapiro, Shea Ruhly
preprint en

Abstract

Neuropathic pain is common and debilitating among diabetics. The reactive glycolytic metabolite methylglyoxal (MGO) is strongly associated with painful diabetic neuropathy. MGO triggers pain through activation of the integrated stress response (ISR). The underlying molecular mechanisms are unclear. Here, we show that general control nonderepressible 2 (GCN2) kinase acts as a conserved sensor that bridges glycolytic and mitochondrial dysfunction to pain hypersensitivity. In human sensory neurons derived from dorsal root ganglion (DRG), MGO increased eIF2α phosphorylation and suppressed global translation. These effects were blocked upon inhibition of GCN2. Unbiased ribosome profiling of mouse DRG revealed that MGO triggered repression of mRNAs that encode components of the electron transport chain. Based on this observation, mitochondrial dysfunction was examined as a potential upstream trigger for GCN2 activation. MGO directly glycated mitochondrial complex I and increased the NADH/NAD+ ratio. Correcting this redox imbalance via expression of a mitochondrial-targeted bacterial NADH oxidase (mitoLbNOX) prevented ISR activation by MGO. In a streptozotocin-induced mouse model of diabetic neuropathy, pharmacological GCN2 inhibition or sensory neuron-specific conditional deletion significantly attenuated mechanical allodynia. Calcium imaging revealed that genetic deletion of GCN2 reduced calcium influx in response to an agonist of TRPA1. Finally, expression of mitoLbNOX using adeno-associated viruses (AAV) in DRG sensory neurons in vivo reduced streptozotocin-induced mechanical hypersensitivity. Our findings demonstrate that GCN2 is a central, conserved driver of translational dysregulation downstream of mitochondrial redox stress in diabetic pain. This work highlights the critical role of mitochondrial function and translational control as key drivers of painful diabetic neuropathy.

bioRxiv (Cold Spring Harbor Laboratory)
University of Wisconsin–Madison (US), Washington University in St. Louis (US)
National Institute of Neurological Disorders and Stroke
Good health and well-being
Pain Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon